Document is current
Any future updates will be listed below
-
Authors
Furuland, Hans
Larsson, Anders Olof
Bjellerup, Per
Uhde, Milica
Cars, Thomas
Almstedt, Matilda
Svensson, Maria K.
-
Funding
Funding for this research was provided by:
Uppsala University
- License Information
-
More Information
Article History
Received: 18 November 2024
Accepted: 21 April 2025
First Online: 28 April 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and was approved by the Swedish Ethical Review Authority (approval number 2022-01051-01 and 2022-06306-02). All data used in the study were secondary data that was pseudonymized, and presented on an aggregated level ensuring that no individual can be identified. Given the nature of the study, informed consent was not required by Swedish Ethical Review Authority.
: Not applicable.
: HF has received consultancy fees from AstraZeneca, GSK, Vifor Pharma Nordiska AB, Bayer and Amgen. MKS has received honoraria from Amgen, AstraZeneca, Boehringer Ingelheim, GSK, NovoNordisk and Vifor Pharma Nordiska AB. AOL has received consultancy fees from Vifor Pharma Nordiska AB. TC and MA are employees at Sence Research AB, which is a company in biostatistics and epidemiology that received payment from Vifor Pharma Nordiska AB for project management, data management and statistical analysis during the conduct of the study.
